CN106552240A - A kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy - Google Patents
A kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy Download PDFInfo
- Publication number
- CN106552240A CN106552240A CN201710030781.2A CN201710030781A CN106552240A CN 106552240 A CN106552240 A CN 106552240A CN 201710030781 A CN201710030781 A CN 201710030781A CN 106552240 A CN106552240 A CN 106552240A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- depression
- cyclomastopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy, prescription is made up of crude drug such as Radix Bupleuri by weight, Rhizoma Cyperi, Rhizoma Chuanxiong, Fructus Hordei Germinatus, Pericarpium Citri Reticulatae, the Radix Paeoniae Alba, Cortex Moutan, Semen Vaccariae, Radix Notoginseng, Radix Ranunculi Ternati, Fructus Trichosanthis, Rhizoma Sparganii, Rhizoma Curcumae, Radix Glycyrrhizaes, and the preparation of oral Chinese medicine plaster is completed according to the preparation method allowed by pharmaceutical practice after the prescription dispensing.The present invention has the advantages that short treating period, instant effect, cure rate are high, and it can effectively treat the disease of cyclomastopathy, evident in efficacy.
Description
Technical field
The present invention relates to a kind of Chinese medicine for treating cyclomastopathy, refers in particular to one kind and treats qi depression to blood stasis phlegm stagnation type breast
The oral Chinese medicine cream of gland hypertrophy.
Background technology
Cyclomastopathy is common gynecological disease, common disease.In China, the age of onset of cyclomastopathy it is many 20～44 years old it
Between, sickness rate accounts for the 40% of the women of child-bearing age, accounts for the 70～78% of mastopathy, is gradually increasing trend in recent years.Grind in a large number
Study carefully and show, the progressive differentiation of cyclomastopathy can cause canceration, thus cause people's common concern.
Cyclomastopathy is the normal breast tissue structure disturbance caused due to mammary gland physiological overgrown and subinvolution,
It is the benign change of the not only noninflammatory but also non-tumor of mammary gland tissue, in close relations with endocrine regulation, its basic pathology change is
The hypertrophy of the acinus, conduit and fibrous connective tissue of mammary gland.At present, the method for clinical treatment cyclomastopathy is mainly controlled with medicine
Based on treatment, doctor trained in Western medicine adopts hormone therapy, but the hormone therapy cycle is long, high recurrence rate, large side effects；And the country is controlled using Chinese medicine
Treat, but curative effect is again not ideal enough.
The content of the invention
It is an object of the invention to provide a kind of be used to treat cyclomastopathy and have dispersing the stagnated live-QI to relieve the stagnation of QI, vital energy regualting and blood circulation-promoting, only stimulate the menstrual flow
The oral Chinese medicine cream of the functions such as pain, can effectively treat qi depression to blood stasis phlegm stagnation type cyclomastopathy.
The invention provides a kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy, the prescription of the Chinese medicinal ointment by
Following crude drug component composition by weight：Radix Bupleuri 45-60 parts, Rhizoma Cyperi 35-50 parts, Rhizoma Chuanxiong 35-50 parts, Fructus Hordei Germinatus 35-50
Part, Pericarpium Citri Reticulatae 45-60 parts, Radix Paeoniae Alba 70-100 parts, Cortex Moutan 45-60 parts, Semen Vaccariae 35-50 parts, Radix Notoginseng 15-30 parts, Radix Ranunculi Ternati
35-50 parts, Fructus Trichosanthis 45-60 parts, Rhizoma Sparganii 15-30 parts, Rhizoma Curcumae 15-30 parts, Radix Glycyrrhizae 15-30 parts.
Present invention also offers a kind of preparation method of the Chinese medicine plaster for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy, i.e.,
Preparation method according to being allowed by pharmaceutical practice after the prescription dispensing completes the preparation of the Chinese medicinal ointment.Conventional tradition side
Formula is that ten four Chinese medicine is put in kettle, discharge water not medical material, repeatedly decoct 3 times, filtration is squeezed the juice, add adjuvant Mel, core
Fructus Persicae etc., heating are condensed into paste, and several oral is taken according to quantity.
The present invention choosing by Radix Bupleuri, Rhizoma Cyperi, Rhizoma Chuanxiong, Fructus Hordei Germinatus, Pericarpium Citri Reticulatae, the Radix Paeoniae Alba, Cortex Moutan, Semen Vaccariae, Radix Notoginseng, Radix Ranunculi Ternati,
The ten four Chinese medicine thing such as Fructus Trichosanthis, Rhizoma Sparganii, Rhizoma Curcumae, Radix Glycyrrhizae is constituted, and causes each medicine to produce cooperative effect these drug regimens, so as to
Being capable of effectively treatment cyclomastopathy.Radix Bupleuri, Rhizoma Cyperi in side, master enter Liver Channel, adjust and reach irritability, dispersing the stagnated live-QI to relieve the stagnation of QI, regulating QI to relieve pain, Rhizoma Chuanxiong,
Fructus Hordei Germinatus are soothing the liver to put down strongly fragrant, promoting flow of QI and blood, helps the stasis of Radix Bupleuri solution Liver Channel, Pericarpium Citri Reticulatae regulating qi-flowing for activating stagnancy, the Radix Paeoniae Alba, Radix Glycyrrhizae nourishing blood to suppress the hyperactive liver, emergency
Pain relieving, Cortex Moutan, Semen Vaccariae, pseudo-ginseng blood-circulation-invigovating stasis-dispelling and pain-killing, with Fructus Trichosanthis, Radix Ranunculi Ternati match, dredge latex dust, resolving sputum detumescence, it is soft
Hard eliminating stagnation, Rhizoma Sparganii, Rhizoma Curcumae promoting the circulation of QI to relieve pain, Rhizoma Chuanxiong can also descend regulating menstruation water, Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, common dispersing the stagnated live-QI to relieve the stagnation of QI vital energy regualting and blood circulation-promoting to lead to
Jing blood stasis dispelling disappears.This drug regimen has the functions such as dispersing the stagnated live-QI to relieve the stagnation of QI, vital energy regualting and blood circulation-promoting, inducing menstruation to relieve menalgia, is generally taking a two weeks left side
It is right, it is possible to which that effectively relief of symptoms even disappears, at most need just to cure completely for three months, generally the present invention is referred to as
Resolving depression cream.The present invention has the advantages that short treating period, instant effect, cure rate are high, and it can effectively treat the disease of cyclomastopathy,
It is evident in efficacy.
Specific embodiment
With reference to embodiment, the invention will be further described：
The present invention is mainly made up of the crude drug of following weight portion：
Radix Bupleuri 45-60g, Rhizoma Cyperi 35-50g, Rhizoma Chuanxiong 35-50g, Fructus Hordei Germinatus 35-50g, Pericarpium Citri Reticulatae 45-60g, Radix Paeoniae Alba 70-100g, Cortex Moutan
45-60g, Semen Vaccariae 35-50g, Radix Notoginseng 15-30g, Radix Ranunculi Ternati 35-50g, Fructus Trichosanthis 45-60g, Rhizoma Sparganii 15-30g, Rhizoma Curcumae 15-
30g, Radix Glycyrrhizae 15-30g.
Embodiment 1：In the present invention, the consumption of each crude drug is：
Radix Bupleuri 60g, Rhizoma Cyperi 50g, Rhizoma Chuanxiong 50g, Fructus Hordei Germinatus 50g, Pericarpium Citri Reticulatae 60g, Radix Paeoniae Alba 100g, Cortex Moutan 60g, Semen Vaccariae 50g, three
Seven 30g, Radix Ranunculi Ternati 50g, Fructus Trichosanthis 60g, Rhizoma Sparganii 30g, Rhizoma Curcumae 30g, Radix Glycyrrhizae 30g.
By ten above-mentioned four Chinese medicine Radix Bupleuri 60g, Rhizoma Cyperi 50g, Rhizoma Chuanxiong 50g, Fructus Hordei Germinatus 50g, Pericarpium Citri Reticulatae 60g, Radix Paeoniae Alba 100g, Paeonia suffruticosa
Skin 60g, Semen Vaccariae 50g, Radix Notoginseng 30g, Radix Ranunculi Ternati 50g, Fructus Trichosanthis 60g, Rhizoma Sparganii 30g, Rhizoma Curcumae 30g, Radix Glycyrrhizae 30g, decoct 3 repeatedly
Time, filtration is squeezed the juice, and adds adjuvant（Mel, Semen Juglandiss）, heating is condensed into and obtains final product, and takes daily at twice.
Embodiment 2：In the present invention, the consumption of each crude drug can be：
Radix Bupleuri 45g, Rhizoma Cyperi 35g, Rhizoma Chuanxiong 35g, Fructus Hordei Germinatus 35g, Pericarpium Citri Reticulatae 45g, Radix Paeoniae Alba 70g, Cortex Moutan 45g, Semen Vaccariae 35g, three
Seven 15g, Radix Ranunculi Ternati 35g, Fructus Trichosanthis 45g, Rhizoma Sparganii 15g, Rhizoma Curcumae 15g, Radix Glycyrrhizae 15g, are decocted 3 times repeatedly, and filtration is squeezed the juice, and add adjuvant
（Mel, Semen Juglandiss）, heating is condensed into and obtains final product, and takes daily at twice.
Embodiment 3：In the present invention, the consumption of each crude drug can be：
Radix Bupleuri 50g, Rhizoma Cyperi 40g, Rhizoma Chuanxiong 40g, Fructus Hordei Germinatus 40g, Pericarpium Citri Reticulatae 50g, Radix Paeoniae Alba 85g, Cortex Moutan 50g, Semen Vaccariae 40g, three
Seven 20g, Radix Ranunculi Ternati 40g, Fructus Trichosanthis 50g, Rhizoma Sparganii 20g, Rhizoma Curcumae 20g, Radix Glycyrrhizae 20g.Preparation method is ibid.
Experimental example
Diagnostic criteria
Diagnostic criteria is with reference to the 8th session discussing revision of breast disease Professional Committee of Chinese surgery of Chinese medicine association in 2002《Breast
The disease diagnosis of gland hypertrophy, dialectical and the standard of curative effect evaluation》.
Primary symptom：Breast twinge；Lump is in multiformity, and obscure boundary, matter are tough；Tongue is dark red or livid purple, or tongue side point have the stasis of blood or
Sublingual venation is thick swollen, livid purple.
Secondary disease：Distending pain of the breast, lump be not very related to menstruation, emotion；Delayed period, passes through freely or with stasis of blood block；Tongue
Greasy fur, hesitant pulse, string or cunning.
It is diagnosable with+2 diseases of above-mentioned 3 primary symptoms or 2 primary symptoms.
Test example：Local 100 proliferation of mammary gland patient are selected, is taken of the invention secondary daily, is serviced once sooner or later, three to five
After it, pain symptom disappears, and after continuing one to two moon of medication, all cures and eradicates.Cure rate is up to 100%.The present invention is avoided
Have an injection and perform an operation, patient will not be damaged, short treating period, instant effect, cure rate are high, substantially reduce patient suffering.
Claims (2)
1. a kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy, prescription is by following crude drug group by weight
Part composition：Radix Bupleuri 45-60 parts, Rhizoma Cyperi 35-50 parts, Rhizoma Chuanxiong 35-50 parts, Fructus Hordei Germinatus 35-50 parts, Pericarpium Citri Reticulatae 45-60 parts, Radix Paeoniae Alba 70-100
Part, Cortex Moutan 45-60 parts, Semen Vaccariae 35-50 parts, Radix Notoginseng 15-30 parts, Radix Ranunculi Ternati 35-50 parts, Fructus Trichosanthis 45-60 parts, Rhizoma Sparganii
15-30 parts, Rhizoma Curcumae 15-30 parts, Radix Glycyrrhizae 15-30 parts.
2. the preparation method of the Chinese medicinal ointment of qi depression to blood stasis phlegm stagnation type cyclomastopathy is treated according to claim 1, according to institute
The preparation method allowed by pharmaceutical practice after stating prescription dispensing completes the preparation of the Chinese medicine plaster.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710030781.2A CN106552240A (en) | 2017-01-17 | 2017-01-17 | A kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710030781.2A CN106552240A (en) | 2017-01-17 | 2017-01-17 | A kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106552240A true CN106552240A (en) | 2017-04-05 |
Family
ID=58446344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710030781.2A Pending CN106552240A (en) | 2017-01-17 | 2017-01-17 | A kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106552240A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110841036A (en) * | 2019-11-24 | 2020-02-28 | 江苏黄河药业股份有限公司 | Traditional Chinese medicine composition for treating mammary nodules and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1555816A (en) * | 2003-12-31 | 2004-12-22 | 彭吉祥 | Medicne for treating proliferation of mammary gland and its preparing process |
| CN101632817A (en) * | 2008-07-24 | 2010-01-27 | 夏范音 | Chinese medicinal composition for treating breast lumps |
| CN105770609A (en) * | 2016-04-27 | 2016-07-20 | 罗翔 | Traditional Chinese medicine decoction for treating liver depression, qi stagnation and phlegm stasis type breast hyperplasia |
-
2017
- 2017-01-17 CN CN201710030781.2A patent/CN106552240A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1555816A (en) * | 2003-12-31 | 2004-12-22 | 彭吉祥 | Medicne for treating proliferation of mammary gland and its preparing process |
| CN101632817A (en) * | 2008-07-24 | 2010-01-27 | 夏范音 | Chinese medicinal composition for treating breast lumps |
| CN105770609A (en) * | 2016-04-27 | 2016-07-20 | 罗翔 | Traditional Chinese medicine decoction for treating liver depression, qi stagnation and phlegm stasis type breast hyperplasia |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110841036A (en) * | 2019-11-24 | 2020-02-28 | 江苏黄河药业股份有限公司 | Traditional Chinese medicine composition for treating mammary nodules and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN101337045B (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN104107395A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
| CN101380381B (en) | Traditional Chinese medicine for treating hypogalactia | |
| CN106552240A (en) | A kind of Chinese medicinal ointment for treating qi depression to blood stasis phlegm stagnation type cyclomastopathy | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN100381155C (en) | Medicine for treating mammary glands hyperplasia | |
| CN102600335B (en) | Traditional Chinese medicine for treating postpartum hypogalactia | |
| CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
| CN101259214B (en) | Medicine for treating hyperplasia of mammary glands | |
| CN103191369B (en) | Chinese medicinal composition for treating mammary gland hyperplasia | |
| CN102813746B (en) | Traditional Chinese medicine composition for treating numbness of fingers | |
| CN105853930A (en) | Traditional Chinese medicine composition for treating depression | |
| CN101396534B (en) | Traditional Chinese medicine for treating lobular hyperplasia of mammary gland | |
| CN104189268A (en) | Chinese medicinal preparation for treating postpartum irregular menstruation | |
| CN104352700B (en) | A kind of Chinese medicine composition for treating protrusion of lumber intervertebral disc | |
| CN103768366B (en) | Traditional Chinese medicine preparation for treating proliferation of mammary gland | |
| CN103356962B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN106511711A (en) | Traditional Chinese medicine formula for treating breast cancer | |
| CN102552803A (en) | Chinese medicinal formulation for relieving breast tenderness during menstruation | |
| CN105687909A (en) | Traditional Chinese medicine composition for treating dysuria | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation | |
| CN105213960A (en) | For controlling the Chinese powder medicine of cyclomastopathy | |
| CN103520639B (en) | Traditional Chinese medicine for treating chronic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170405 |